RS-102221
RS-102221 is a drug used in scientific research, which acts as a highly selective 5-HT2A receptor antagonist. It has been used to distinguish 5-HT2A effects in a variety of in vivo and in vitro studies.
Pharmacology[edit | edit source]
RS-102221 is a potent and selective antagonist for the 5-HT2A receptor, one of the various subtypes of the serotonin receptor. It has been used in scientific research to help distinguish the effects of this receptor subtype from others in the serotonin receptor family.
Uses in Research[edit | edit source]
RS-102221 has been used in a variety of in vivo and in vitro studies to help understand the role of the 5-HT2A receptor in various physiological processes and disease states. These include studies on depression, anxiety, schizophrenia, and drug addiction.
See Also[edit | edit source]
References[edit | edit source]
RS-102221 Resources | ||
---|---|---|
|
|
Translate to: East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD